Publication Name	World Journal of Virology
Manuscript ID	88487
Country	Italy

Received	2023-09-26 12:26
Peer-Review Started	2023-09-26 12:28
To Make the First Decision
Return for Revision	2023-11-23 03:34
Revised	2023-11-23 13:25
Second Decision	2023-12-12 02:53
Accepted by Journal Editor-in-Chief	2023-12-17 07:41
Accepted by Executive Editor-in-Chief	2023-12-19 08:24
Articles in Press	2023-12-19 08:24
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-12-24 07:40
Typeset the Manuscript	2024-02-06 07:09
Publish the Manuscript Online	2024-03-11 14:44

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Minireviews
Article Title	Hepatitis B virus reactivation in patients treated with monoclonal antibodies
Manuscript Source	Invited Manuscript
All Author List	Silvia De Pauli, Martina Grando, Giovanni Miotti and Marco Zeppieri
ORCID	Author(s) ORCID Number Silvia De Pauli http://orcid.org/0000-0002-0486-0441 Martina Grando http://orcid.org/0000-0002-1877-3621 Giovanni Miotti http://orcid.org/0000-0003-3185-7595 Marco Zeppieri http://orcid.org/0000-0003-0999-5545
Funding Agency and Grant Number
Corresponding Author	Marco Zeppieri, BSc, MD, PhD, Doctor, Doctor, Department of Ophthalmology, University Hospital of Udine, p.le S. Maria della Misericordia 15, Udine 33100, Italy. markzeppieri@hotmail.com
Key Words	Hepatitis B virus; Reactivation; Acute infection; Chronic infection; Monoclonal antibodies
Core Tip	Reactivation of hepatitis B (HBV) induces a rapid and acute increase in viral replication in a patient with chronic HBV infection or prior HBV exposure. There is an increased risk of HBV reactivation in patients treated with monoclonal antibodies. The organ damage can be due to various mechanisms and risk factors that activate the cascade of inflammatory responses such as direct infection. It is of clinical importance to diagnose, manage, and treat individuals, especially those at risk. Patient outcomes, success of therapy, prevention of complications, and management of existing comorbidities depend on the correct multidisciplinary management in patients at risk.
Publish Date	2024-03-11 14:44
Citation	De Pauli S, Grando M, Miotti G, Zeppieri M. Hepatitis B virus reactivation in patients treated with monoclonal antibodies. World J Virol 2024; 13(1): 88487
URL	https://www.wjgnet.com/2220-3249/full/v13/i1/88487.htm
DOI	https://dx.doi.org/10.5501/wjv.v13.i1.88487

Full Article (PDF)	WJV-13-88487-with-cover.pdf
Full Article (Word)	WJV-13-88487.docx
Manuscript File	88487-Review-Filipodia.docx
Answering Reviewers	88487-Answering reviewers.pdf
Audio Core Tip	88487-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	88487-Conflict-of-interest statement.pdf
Copyright License Agreement	88487-Copyright license agreement.pdf
Peer-review Report	88487-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	88487-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	88487-Bing-Liu JH-2.png
Scientific Misconduct Check	88487-CrossCheck.png
Scientific Editor Work List	88487-Scientific editor work list.pdf
CrossCheck Report	88487-CrossCheck report.pdf